NPAT swung to NZ$4.0m profit while operating cash burn widened to NZ$1.5m

Revenue remained immaterial at NZ$24k versus NZ$43k a year earlier, well short of any operating scale and noted in the release as down 54% on a continuing-operations basis (subject to a basis-discontinuity caveat that limits clean year-on-year revenue interpretation).

The balance sheet was rebuilt around that result. Total assets rose to NZ$16.7m from NZ$9.6m, equity grew to NZ$15.6m from NZ$8.7m (+NZ$7.0m), and gross borrowings fell to NZ$0.04m from NZ$1.7m as the convertible note was largely extinguished. Cash held was broadly unchanged at NZ$0.6m.

NPAT printed at NZ$4.0m while operating cash flow was minus NZ$1.5m. With revenue at NZ$24k and continuing operations posting a NZ$4.1m operating profit, the reported earnings cannot have been generated by the business's commercial activity in the period. This matters because the headline result tells the reader nothing about whether the underlying mine and plant are economic.

The balance sheet expansion is not earned retained profit. Total assets sit NZ$3.6m above Annolyse's historical baseline mean of NZ$13.1m, and equity grew by NZ$7.0m while cash was effectively flat. The NZ$1.7m reduction in convertible note borrowings, combined with prior-period commentary on a NZ$2.4m capital raise and partial convertible debt conversion, implies the equity build is funded by securities issuance and non-cash asset movements rather than trading.

Operating burn accelerated. The operating cash outflow widened by NZ$0.7m even as borrowings were retired, which means continued funding capacity depends on further capital issuance or the plant finally generating concentrate revenue at scale.

Commentary frames the Terra Firma plant as ready to process volumes and refers to "anticipated revenue generated from concentrate produced from our own plant", but does not commit to a production rate or timing.

The interim-to-full-year shape is unusual: HY25 NPAT was a loss of roughly NZ$0.9m, so the full-year NZ$4.0m profit requires a second-half positive swing of close to NZ$5m. With H2 revenue still negligible, that swing almost certainly reflects a non-operating item booked in the second half rather than a step-change in trading. This matters because it caps how much weight the FY25 print should carry as a baseline.

Revenue is below NZ$25k, operating cash flow is NZ$1.5m negative, and the reported profit is not visible in the cash statement. Prior-year commentary disclosed an impairment provision against assets, which makes a reversal or revaluation in FY25 a plausible non-cash explanation for the swing — but the release excerpts supplied do not confirm the specific driver, so the source of the profit remains unresolved here.

The balance sheet improvement is more durable in character but still not operational: debt has been removed (a genuine financial-flexibility gain) and equity expanded, yet the assets supporting that equity have not yet been validated by recurring revenue or positive cash generation. Cash conversion deteriorated against the prior period on the supplied calculation flag, and on these numbers the company continued to burn roughly NZ$1.5m of operating cash to fund development. Until concentrate volumes ramp, reported profit and reported equity should be read as accounting outcomes rather than evidence of a working business model.

This briefing cannot assess the specific accounting driver of the NPAT swing because the supplied release excerpts do not disclose the underlying non-operating item or its valuation basis.